Harmony Biosciences

Earlier today, Harmony Biosciences announced the Company’s Q2 2025 financial results, which included plans in Q3 2025 to announce topline data from the RECONNECT Phase 3 registrational clinical trial in Fragile X syndrome, and continued expansion of our leadership in Sleep/Wake. Read our news release for more information: https://xmrrwallet.com/cmx.pbit.ly/4ljAkep

It’s #NationalInternDay! Every year we have the opportunity to host a Summer Internship Program. And every year we are impressed by the knowledge, ambition, professionalism, and kindness of each of our interns. Thank you to our 2025 interns for your passion for making a difference in the lives of people with #rarediseases. You are the next generation of #lifesciences leaders. We appreciate you and are excited to see what you do in the future! Learn more about career opportunities with Harmony Biosciences:  https://xmrrwallet.com/cmx.pbit.ly/3UDib09 #InHarmony #Biosciences  #Intern #Internship

What an enjoyable night of networking, baseball and community! The Harmony Biosciences team joined more than 500 life sciences professionals at Bases & Breakthroughs at Citizens Bank Park in Philadelphia for an evening that combined networking, baseball, and giving back to the local community. As Title Sponsor of the event, we were proud to partner with Life Science Cares Philadelphia as we work together to fight poverty and create new opportunities across the region.   The event started with a lively pregame at The Navy Yard, complete with food, music, and games, before heading to the ballgame to watch the Philadelphia Phillies on the Boston Red Sox. It was a fun way to celebrate the power of the life sciences community to come together and make a difference.   #Biosciences #LifeSciences #PhillyLifeSciences #SocialImpact  #InHarmony #EmpathyAndInnovation

Today, our Harmony Biosciences team stands with patients, caregivers, and the entire #neuroscience community in celebrating the 12th annual World Brain Day. 🌎🧠   Founded by the World Federation of Neurology, World Brain Day raises awareness about neurological disorders and highlights the importance of brain health for all. This year’s theme, “Brain Health for All Ages,” reminds us that it’s never too early or too late to prioritize brain health.   With patients at the heart of everything we do, our team believes that innovating science can translate into therapeutic possibilities for several disorders that impact the brain. Learn more about our areas of focus here: https://xmrrwallet.com/cmx.pbit.ly/4kQOTpC   #BrainHealth #Neurology #RareDisease #RareDiseases #RareNeurologicalDisease #EmpathyAndInnovation

Harmony Biosciences will be announcing the Company’s Q2 2025 financial results on August 5, 2025, during an earnings call. Learn more: http://xmrrwallet.com/cmx.pbit.ly/44HWj9T   #InvestorRelations #IR #Biosciences #LifeSciences

In honor of #WorldFragileXDay, we are privileged to share the voice of Ashley as she advocates for people impacted by #FragileX syndrome (FXS) including her son, Sebastian. Ashley and Sebastian remind us of why we do what we do. At Harmony Biosciences, we’re guided by empathy and driven by innovation as we work to bring meaningful therapies to individuals impacted by rare neurological diseases like #FXS: https://xmrrwallet.com/cmx.pbit.ly/4l1QSHS #FXSAwareness #RareDisease #CaregiverVoices #Neuroscience #Biosciences #Pharma #EmpathyandInnovation

Prader-Willi syndrome (PWS) is a rare genetic neurological disorder with symptoms likely related to dysfunction of the hypothalamus - a small brain area that controls crucial bodily functions, including sleep/wake balance and regulating hunger and satiety. At Harmony Biosciences, we’re committed to raising awareness, advancing research, and advocating for improved screening and support for the #PWS community. Learn more: https://xmrrwallet.com/cmx.pbit.ly/44BfaU4 #PraderWilliSyndrome #RareDisease #Neuroscience

On July 17, 2025, Harmony Biosciences’ Management Team will be participating in the virtual H.C. Wainwright "HCW@Home" series. Learn more about our evolving pipeline and commitment to developing new treatment options for people living with rare #neurological diseases who have unmet medical needs. More information: https://xmrrwallet.com/cmx.pbit.ly/3Uc2Nrn #Biosciences #LifeSciences #InvestorRelations #IR

Our team was honored to attend and support the United In Hope: International Prader-Willi Syndrome Conference held in Arizona, hosted by the Prader Willi Syndrome Association | USA, the Foundation For Prader-Willi Research, and the International Prader-Willi Syndrome Organisation (IPWSO). We proudly support these organizations and their mission to advance care, research, and resources for individuals living with Prader-Willi syndrome. Events like this are critical for fostering collaboration, driving scientific progress, and strengthening the global community of families, caregivers, clinicians, and advocates dedicated to improving outcomes for those affected by #PWS. It was inspiring to connect with so many families and advocates who generously shared their experiences and perspectives. These meaningful conversations reinforce our commitment to putting patients and caregivers at the center of everything we do. Learn more about how we’re working to help people living with rare neurological disease, like #PraderWilli syndrome, who have unmet medical needs: https://xmrrwallet.com/cmx.pbit.ly/4ls8RaO #PraderWilliSyndrome #RareDiseases #Raredisease #EmpathyAndInnovation

Every individual with #Dravet syndrome deserves to be seen, supported, and fought for; including children like Max, whose strength reminds us why our work matters. In recognition of #DravetSyndromeAwarenessDay, we stand with the families, caregivers, advocates, and researchers working tirelessly to bring visibility, understanding, and better care to those affected by this rare and severe form of #epilepsy. #EpilepsyAwareness #RareDisease #Advocacy #Dravetsyndrome #EmpathyandInnovation